Product Information
TRI-LO-ESTARYLLA TABLET is a generic product labeled by Xiromed LLC, priced at $0.1083 per EA under NDC 70700012085. Its NADAC has been published 419 times since Aug 15, 2018.
FDA first approved this application on Jun 29, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Xiromed LLCNDC
70700012085
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA091232FDA Approved
6/29/2015
TE Code
AB
On Market Since
1/1/2018
Price Statistics
The NADAC for TRI-LO-ESTARYLLA TABLET has been published 419 times since Aug 15, 2018, and over the history we have for it it has declined 48.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1083 per EA |
|---|---|
| All-time high | $0.2607 (Jun 12, 2019) |
| All-time low | $0.0903 (Nov 20, 2024) |
| 52-week high | $0.1148 |
| 52-week low | $0.1046 |
| Median price | $0.1627 |
| Average price | $0.1622 |
| Largest weekly change | -27.8% (Apr 17, 2024) |
| Weeks tracked | 419 |
| Tracking since | Aug 15, 2018 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRI-LO-ESTARYLLA TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRI-LO-ESTARYLLA TABLET, manufactured by Xiromed LLC, is $0.1083 per EA (NDC 70700012085), effective Aug 19, 2026.
How has the price of TRI-LO-ESTARYLLA TABLET changed over time?
Over the history we have for it, the NADAC for TRI-LO-ESTARYLLA TABLET has declined 48.4%. It has been tracked across 419 weekly CMS publications since Aug 15, 2018.
What are the highest and lowest recorded NADAC prices for TRI-LO-ESTARYLLA TABLET?
Since Aug 15, 2018, the NADAC for TRI-LO-ESTARYLLA TABLET has ranged from a low of $0.0903 (Nov 20, 2024) to a high of $0.2607 (Jun 12, 2019), with a median of $0.1627 per EA.
Are there cheaper alternatives to TRI-LO-ESTARYLLA TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRI-LO-ESTARYLLA TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TRI-LO-ESTARYLLA TABLET?
TRI-LO-ESTARYLLA TABLET (NDC 70700012085) is labeled by Xiromed LLC, and CMS classifies it as a generic product.